Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia

OBJECTIVE: Patients with congenital adrenal hyperplasia (CAH) require lifelong therapy with glucocorticoids to suppress androgen excess and substitute for deficient cortisol. An important aspect of care is the prevention of metabolic sequelae. In infants, potentially lethal nocturnal hypoglycaemia h...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubinski, Ilja, Bechtold-Dalla Pozza, Susanne, Debor, Belana, Nowotny, Hannah Franziska, Reisch, Nicole, Tschaidse, Lea, Schmidt, Heinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683536/
https://www.ncbi.nlm.nih.gov/pubmed/37218136
http://dx.doi.org/10.4274/jcrpe.galenos.2023.2023-3-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683536/
https://www.ncbi.nlm.nih.gov/pubmed/37218136
http://dx.doi.org/10.4274/jcrpe.galenos.2023.2023-3-5

Ejemplares similares